MML Investors Services
ESPR

MML Investors Services’s Esperion Therapeutics ESPR Stock Holding History

MML Investors Services’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,511
Closed -$79.6K – 3050
2025
Q4 		$79.6K Sell
21,511
-1,567
-7% -$5.06K ﹤0.01% 2949
2025
Q3 		$61.2K Buy
23,078
+330
+1% +$638 ﹤0.01% 2858
2025
Q2 		$22K Buy
22,748
+5,595
+33% +$5.6K ﹤0.01% 2797
2025
Q1 		$25K Buy
17,153
+4,362
+34% +$8.04K ﹤0.01% 2673
2024
Q4 		$28K Buy
12,791
+413
+3% +$964 ﹤0.01% 2644
2024
Q3 		$20K Buy
12,378
+331
+3% +$668 ﹤0.01% 2557
2024
Q2 		$27K Buy
+12,047
New +$28.3K ﹤0.01% 2457

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return